Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Edward Garmey"'
Autor:
James L Gulley, Rong Deng, Carl Millward, Jason M Redman, Yao Chiang, Ariel Niedecken, Kacy Stadtmiller, Edward Garmey, Vincent Poon, Michael A Asensio, Janice Lansita, Kyle P Carter, Ellen K Wagner, Erica L Stone
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/cd7653e4b6fc47cc83ad4632ba2809b7
Autor:
Syed Kazmi, Lijun Sun, Angela Alistar, Ezra Cohen, Timothy Yap, Devalingam Mahalingam, Justin C Moser, Edward Garmey, Teresa Mooneyham
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/d0c3edf696b9452ba0f11318b442f49d
Autor:
Janet M. Grimes, Shahin Lockman, Monty Montano, Ric Marlink, Trevor Peter, Max Essex, Poloko Kebaabetswe, Roger L. Shapiro, Soyeon Kim, Ibou Thior, Edward Garmey, Lesego Gabaitiri, Su-Yuan Chang
Publikováno v:
Patient education and counseling. 65(3)
To determine uptake and socio-demographics predictors of acceptance of voluntary counseling and testing (VCT) among post-partum women in Botswana.Women attending maternal and child health clinics for their first post-partum or well baby visit in thre
Autor:
Stephen M. Keefe, Meliessa Hennessy, Orvar Gunnarsson, Ronac Mamtani, David Vaughn, Jean Hoffman-Censits, Katherine Nathanson, Priti Lal, Daniel Pryma, Scott Eliasof, Edward Garmey, Roger B. Cohen, Naomi B. Haas
Publikováno v:
Cancer Research. 74:CT340-CT340
Introduction: The inactivation of VHL occurs in most clear cell RCC (ccRCC) tumors and gives rise to the HIF hypoxia response program and to tumor angiogenesis. While antiangiogenic therapies are active in ccRCC, resistance develops in all pts. We hy